Huaier aqueous extract suppresses human breast cancer cell proliferation through inhibition of estrogen receptor α signaling

International Journal of Oncology

Volumn 43, Issue 1, 2013, Pages 321-328

  Wang, Xiaolong ^a   Zhang, Ning ^a   Huo, Qiang ^a   Sun, Mingjuan ^a   Lv, Shangge ^a   Yang, Qifeng ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Breast cancer; Estrogen receptor; Huaier; Nuclear factor B

Indexed keywords

ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR ALPHA; HUAIER AQUEOUS EXTRACT; MESSENGER RNA; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CELL CULTURE; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; DRUGS, CHINESE HERBAL; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NF-KAPPA B; SIGNAL TRANSDUCTION; TRAMETES;

EID: 84879653634     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.1947     Document Type: Article

References (42)

1. Hedden A, Müller V and Jensen EV: A new interpretation of antiestrogen action. Ann NY Acad Sci 761: 109-120, 1995.
2. Klinge CM: Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res 29: 2905-2919, 2001.
3. Kushner PJ, Agard DA, Greene GL, et al: Estrogen receptor pathways to AP-1. J Steroid Biochem Mol Biol 74: 311-317, 2000. (Pubitemid 32126243)
4. Safe S: Transcriptional activation of genes by 17β-estradiol through estrogen receptor-Sp1 interactions. Vitam Horm 62: 231-252, 2001.
5. Dotzlaq H, Leygue E, Watson PH and Murphy LC: Expression of estrogen receptor-β in human breast tumors. J Clin Endocrinol Metab 82: 2371-2374, 1997. (Pubitemid 27287615)
6. Ali S and Coombes RC: Estrogen receptor alpha in human breast cancer: occurrence and significance. J Mammary Gland Biol Neoplasia 5: 271-281, 2000. (Pubitemid 32156528)
7. Korach KS, Couse JF, Curtis SW, et al: Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes. Recent Progr Horm Res 51: 159, 1996.
8. Bocchinfuso WP and Korach KS: Mammary gland development and tumorigenesis in estrogen receptor knockout mice. J Mammary Gland Biol Neoplasia 2: 323-334, 1997.
9. Shaaban AM, O'Neill PA, Davies MPA, et al: Declining estrogen receptor-[beta] expression defines malignant progression of human breast neoplasia. American J Surg Pathol 27: 1502-1512, 2003. (Pubitemid 37486611)
10. Gralow JR: Optimizing the treatment of metastatic breast cancer. Breast Cancer Res Treat 89: 9-15, 2005.
11. Shang Y and Brown M: Molecular determinants for the tissue specificity of SERMs. Science 295: 2465-2468, 2002. (Pubitemid 34270263)
12. Osborne CK, Zhao HH and Fuqua SAW: Selective estrogen receptor modulators: structure, function, and clinical use. J Clin Oncol 18: 3172-3186, 2000.
13. McCarthy TL, Clough ME, Gundberg CM and Centrella M: Expression of an estrogen receptor agonist in differentiating osteoblast cultures. Proc Natl Acad Sci USA 105: 7022-7027, 2008. (Pubitemid 351754523)
14. Cassady JM, Baird WM and Chang CJ: Natural products as a source of potential cancer chemotherapeutic and chemopreventive agents. J Nat Prod 53: 23-41, 1990. (Pubitemid 20152034)
15. Zhang N, Kong X, Yan S, Yuan C and Yang Q: Huaier aqueous extract inhibits proliferation of breast cancer cells by inducing apoptosis. Cancer Sci 101: 2375-2383, 2010.
16. Wang X, Zhang N, Huo Q and Yang Q: Anti-angiogenic and antitumor activities of Huaier aqueous extract. Oncol Rep 28: 1167-1175, 2012.
17. Ren J, Zheng C, Feng G, et al: Inhibitory effect of extract of fungi of Huaier on hepatocellular carcinoma cells. J Huazhong Univ Sci Technolog Med Sci 29: 198-201, 2009.
18. Xu X, Wei Q, Wang K, et al: Anticancer effects of Huaier are associated with down-regulation of P53. Asian Pac J Cancer Prev 12: 2251-2254, 2011.
19. Sun Y, Sun T, Wang F, et al: A polysaccharide from the fungi of Huaier exhibits anti-tumor potential and immunomodulatory effects. Carbohydr Polym 92: 577-582, 2013.
20. Lippman M, Bolan G and Huff K: The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res 36: 4595-4601, 1976.
21. Dupont J, Karas M and LeRoith D: The potentiation of estrogen on insulin-like growth factor I action in MCF-7 human breast cancer cells includes cell cycle components. J Biol Chem 275: 35893-35901, 2000.
22. Zhu J, Li X, Kong X, et al: Testin is a tumor suppressor and prognostic marker in breast cancer. Cancer Sci 103: 2092-2101, 2012.
23. Altucci L, Addeo R, Cicatiello L, et al: 17beta-estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G (1)-arrested human breast cancer cells. Oncogene 12: 2315, 1996.
24. Kodama F, Greene GL and Salmon SE: Relation of estrogen receptor expression to clonal growth and antiestrogen effects on human breast cancer cells. Cancer Res 45: 2720-2724, 1985. (Pubitemid 15232741)
25. Lu J, Pierron A and Ravid K: An adenosine analogue, IB-MECA, down-regulates estrogen receptor α and suppresses human breast cancer cell proliferation. Cancer Res 63: 6413-6423, 2003. (Pubitemid 37255191)
26. Wormke M, Stoner M, Saville B, et al: The aryl hydrocarbon receptor mediates degradation of estrogen receptor α through activation of proteasomes. Mol Cell Biol 23: 1843-1855, 2003. (Pubitemid 36278799)
27. Wijayaratne AL and McDonnell DP: The human estrogen receptor-α is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators. J Biol Chem 276: 35684-35692, 2001.
28. Horwitz KB, Koseki Y and McGuire WL: Estrogen control of progesterone receptor in human breast cancer: role of estradiol and antiestrogen. Endocrinology 103: 1742-1751, 1978. (Pubitemid 9051866)
29. Dauvois S, White R and Parker MG: The antiestrogen ICI 182780 disrupts estrogen receptor nucleocytoplasmic shuttling. J Cell Sci 106: 1377-1388, 1993. (Pubitemid 24018422)
30. Baker P, Wilton J, Jones C, Stenzel D, Watson N and Smith G: Bile acids influence the growth, oestrogen receptor and oestrogen-regulated proteins of MCF-7 human breast cancer cells. Br J Cancer 65: 566, 1992.
31. Horwitz KB, Mockus MB and Lessey BA: Variant T47D human breast cancer cells with high progesterone-receptor levels despite estrogen and antiestrogen resistance. Cell 28: 633-642, 1982. (Pubitemid 12111931)
32. Rubio M, Werbajh S, Cafferata E, et al: TNF-alpha enhances estrogen-induced cell proliferation of estrogen-dependent breast tumor cells through a complex containing nuclear factor-kappa B. Oncogene 25: 1367-1377, 2005. (Pubitemid 43336465)
33. Fisher B, Costantino JP, Wickerham DL, et al: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90: 1371-1388, 1998. (Pubitemid 28439961)
34. Ali S and Coombes RC: Endocrine-responsive breast cancer and strategies for combating resistance. Nat Rev Cancer 2: 101-112, 2002. (Pubitemid 37328797)
35. Yao K and Jordan VC: Questions about tamoxifen and the future use of antiestrogens. Oncologist 3: 104-110, 1998. (Pubitemid 28213172)
36. Cortesi L, De Matteis E, Rashid I, et al: Distribution of second primary malignancies suggests a bidirectional effect between breast and endometrial cancer: a population-based study. Int J Gynecol Cancer 19: 1358, 2009.
37. Gutierrez MC, Detre S, Johnston S, et al: Molecular changes in tamoxifen-resistant breast cancer: relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase. J Clin Oncol 23: 2469-2476, 2005. (Pubitemid 47050837)
38. Levin ER: Bidirectional signaling between the estrogen receptor and the epidermal growth factor receptor. Mol Endocrinol 17: 309-317, 2003.
39. Osborne C, Wakeling A and Nicholson R: Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action. Br J Cancer 90: S2-S6, 2004. (Pubitemid 38482618)
40. Buijs C, de Vries EG, Mourits MJ and Willemse PH: The influence of endocrine treatments for breast cancer on health-related quality of life. Cancer Treat Rev 34: 640-655, 2008.
41. Klinge CM: Estrogen receptor interaction with co-activators and co-repressors. Steroids 65: 227-251, 2000.
42. Hsu SM, Chen YC and Jiang MC: 17β-estradiol inhibits tumor necrosis factor-α-induced nuclear factor-κB activation by increasing nuclear factor-κB p105 level in MCF-7 breast cancer cells. Biochem Biophys Res Commun 279: 47-52, 2000.